From SciTechDaily
A widely available amino acid may offer a new way to target Alzheimer’s disease before major damage occurs.
Scientists in Japan say a common amino acid already sold as a dietary supplement may help slow key processes linked to Alzheimer’s disease.
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β (Aβ) proteins in both fruit fly and mouse models of Alzheimer’s disease (AD). The compound also appeared to ease brain inflammation and improve behavioral performance in mice.